ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 960 filers reported holding ASTRAZENECA PLC in Q3 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,900 | +15.1% | 50,000 | 0.0% | 0.14% | +37.9% |
| Q1 2024 | $3,388 | +0.6% | 50,000 | 0.0% | 0.10% | +24.1% |
| Q4 2023 | $3,368 | -0.5% | 50,000 | 0.0% | 0.08% | -49.7% |
| Q3 2023 | $3,386 | -52.7% | 50,000 | -50.0% | 0.16% | -87.2% |
| Q2 2023 | $7,157 | +3.1% | 100,000 | 0.0% | 1.29% | +68.3% |
| Q1 2023 | $6,941 | +2.4% | 100,000 | 0.0% | 0.76% | -49.0% |
| Q4 2022 | $6,780 | -100.0% | 100,000 | -66.7% | 1.50% | -48.1% |
| Q3 2022 | $16,452,000 | -58.5% | 300,000 | -50.0% | 2.89% | +141.9% |
| Q2 2022 | $39,642,000 | +497.6% | 600,000 | +500.0% | 1.19% | +57.0% |
| Q1 2022 | $6,634,000 | +13.9% | 100,000 | 0.0% | 0.76% | +98.4% |
| Q4 2021 | $5,825,000 | -3.0% | 100,000 | 0.0% | 0.38% | +3.0% |
| Q3 2021 | $6,006,000 | +0.3% | 100,000 | 0.0% | 0.37% | +1.1% |
| Q2 2021 | $5,990,000 | +20.5% | 100,000 | 0.0% | 0.37% | -11.1% |
| Q1 2021 | $4,972,000 | -0.5% | 100,000 | 0.0% | 0.41% | -16.5% |
| Q4 2020 | $4,999,000 | – | 100,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |